GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncopeptides AB (OTCPK:ONPPF) » Definitions » Price-to-Tangible-Book

Oncopeptides AB (Oncopeptides AB) Price-to-Tangible-Book : (As of Jun. 05, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Oncopeptides AB Price-to-Tangible-Book?

As of today (2024-06-05), Oncopeptides AB's share price is $0.265. Oncopeptides AB's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $-0.01. Hence, Oncopeptides AB's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Oncopeptides AB's Price-to-Tangible-Book or its related term are showing as below:

During the past 10 years, Oncopeptides AB's highest Price to Tangible Book Ratio was 29.91. The lowest was 2.81. And the median was 7.62.

ONPPF's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.78
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Oncopeptides AB's share price is $0.265. Oncopeptides AB's Book Value per Sharefor the quarter that ended in Mar. 2024 was $-0.01. Hence, Oncopeptides AB's P/B Ratio of today is .


Oncopeptides AB Price-to-Tangible-Book Historical Data

The historical data trend for Oncopeptides AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncopeptides AB Price-to-Tangible-Book Chart

Oncopeptides AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 18.56 5.75 2.49 8.95

Oncopeptides AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.24 4.29 5.87 8.95 -

Competitive Comparison of Oncopeptides AB's Price-to-Tangible-Book

For the Biotechnology subindustry, Oncopeptides AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncopeptides AB's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncopeptides AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Oncopeptides AB's Price-to-Tangible-Book falls into.



Oncopeptides AB Price-to-Tangible-Book Calculation

Oncopeptides AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=0.265/-0.006
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Oncopeptides AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Oncopeptides AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncopeptides AB (Oncopeptides AB) Business Description

Traded in Other Exchanges
Address
Vastra Tradgardsgatan 15, Stockholm, SWE, SE-111 53
Oncopeptides AB is a biotech company focused on the research, development, and commercialization of therapies for difficult-to-treat hematological diseases. The company uses its proprietary Peptide Drug Candidate platform (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells. It has focused on the development of the product candidate melflufen (Ygalo), a peptide-conjugated alkylator, belonging to a new class of drugs called Peptidase Enhanced Compounds. Melflufen is intended as an effective treatment for hematological cancers and in particular multiple myeloma.